Top news of the week: 01.09.2020.

#news #pharma #pharmiweb #GlobalGrowthPartners #Staffing #BusinessDevelopment #CareerOpportunities #CareerGrowth #LifeSciences

Career And Jobs

On Aug 25, 2020
@Proclinical shared
Time for a new role? We are looking for specialists from around the world to fill our wide range of exciting business development roles. Visit our page and apply today. https://t.co/fCVTvzHXUS #GlobalGrowthPartners #Staffing #CareerOpportunities #CareerGrowth #BusinessDevelopment https://t.co/dsq3mUXM2A
Open

Business Development jobs

Business Development jobs

Business Development jobs | Proclinical life sciences recruitment. Browse our latest jobs, blogs & industry news.

On Aug 25, 2020
@BiotechWorld shared
Connect Biopharma adds $115M to the pot as it eyes rivalry with Dupixent https://t.co/1eKVv5pt1k https://t.co/xJ12M4rUFo
Open

Connect Biopharma adds $115M to the pot as it eyes rivalry with Dupixent

Connect Biopharma adds $115M to the pot as it eyes rivalry with Dupixent

While Sanofi and Regeneron’s Dupixent racks up the sales, more and more biotechs want a piece of the action.

On Aug 26, 2020
@JohnCendpts shared
Vivek Ramaswamy’s Dermavant team looks to take on Amgen’s $13.4B psoriasis contender Otezla with a promising PhIII readout for a topical rival https://t.co/co2t04ct3S
Open

Vivek Ramaswamy’s Dermavant team looks to take on Amgen’s $13.4B psoriasis contender Otezla with a promising PhIII readout for a topical rival

Vivek Ramaswamy’s Dermavant team looks to take on Amgen’s $13.4B psoriasis contender Otezla with a promising PhIII readout for a topical rival

At first glance, you might not be too impressed with the data from Dermavant’s Phase IIIs for their psoriasis contender tapinarof. The results pale in comparison to the biologics that have ...

On Aug 27, 2020
@pharminews shared
Pharmaceutical Companies https://t.co/SoCJL88CuK #news #pharma #pharmiweb
Open

Pharmaceutical Companies

Pharmaceutical Companies

Europe's Largest Pharma Job Board, PharmiWeb.jobs has a list of the major employers (pharmaceutical, clinical research, biotech, healthcare) in Pharma with job vacancies:AbbottAbbott is a ...

On Aug 27, 2020
@JohnCendpts shared
#3 By @AmberTongPW Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms https://t.co/31wYSBnVLw
Open

Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms

Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms

Jay Mei remembers the exact date he first met BeiGene CEO John Oyler. It was May 14, 2016, and Mei — then an executive director of clinical development at Celgene — accompanied CEO Mark ...

On Aug 27, 2020
@pharminews shared
Pharma Jobs in Australia https://t.co/tV7x2wR4Tr #news #pharma #pharmiweb
Open

Pharma Jobs in Australia

Pharma Jobs in Australia

The Latest Pharma Jobs in Australia.In 1999 PharmiWeb launched what was probably the first dedicated Pharma Job Board in Europe, and since then has maintained its position as the primary ...

On Aug 26, 2020
@MassBio shared
In June, MassBio released its State of Possible 2025 report. To learn how this report will serve as a roadmap for the #LifeSciences for the next 5 years & beyond, we sat down with MassBio’s new Board Chair, & CEO & President of @UnumRx, Chuck Wilson. https://t.co/AFUDa05thu
Open

Sustaining the Legacy of the Massachusetts Life Sciences Cluster

Sustaining the Legacy of the Massachusetts Life Sciences Cluster

To learn more about how this report will serve as a roadmap for the next five years and beyond, we sat down with MassBio’s new Board Chair, and CEO & President of Unum Therapeutics, Chuck ...

On Aug 26, 2020
@pharminews shared
ASLAN PHARMACEUTICALS RESUMES RECRUITMENT OF NEW PATIENTS INTO ASLAN004 STUDY https://t.co/7rT9NzvkJA #news #pharma #pharmiweb
Open

ASLAN PHARMACEUTICALS RESUMES RECRUITMENT OF NEW PATIENTS INTO ASLAN004 STUDY

ASLAN PHARMACEUTICALS RESUMES RECRUITMENT OF NEW PATIENTS INTO ASLAN004 STUDY

Interim, unblinded data from all 3 dose cohorts in MAD study expected in 4Q 2020Singapore, 24 August 2020 – ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology ...